SAUGATUCK CAPITAL COMPANY ANNOUNCES INVESTMENT IN PHARMACEUTIC LITHO & LABEL COMPANY, INC.
Provides Generational Transition for Family-Owned Business
Wilton, CT – October 10, 2014 – Saugatuck Capital Company (“Saugatuck”) is pleased to announce its investment in Pharmaceutic Litho & Label Company, Inc. (“PLLC” or the “Company”), headquartered in Simi Valley, California. Saugatuck provided equity capital through its investment vehicle Saugatuck Capital Company IX LLC which, along with management, owns a majority interest in PLLC. First Niagara Bank provided the senior debt financing and Ironwood Capital provided the mezzanine financing as well as an equity investment. PLLC is a current Good Manufacturing Practices (cGMP) compliant specialty printer that exclusively serves the pharmaceutical, biotech and medical device industries.
Founded in 1982, Saugatuck Capital Company is a long-established private investment firm committed to leveraged recapitalizations and buyouts and growth equity investments in the lower, middle market. Sourcing investment opportunities through its well-established network, Saugatuck invests in service-intensive businesses demonstrating a proven ability to generate stable, growing cash flows where it has the requisite experience to drive accelerated portfolio company performance. For over three decades, the Firm has been dedicated to the philosophy of hands-on value creation in which exceptional management teams, in partnership with Saugatuck’s capital and expertise, build companies of outstanding value.
Founded in 1964, PLLC is a leader in printing and labeling solutions for the highly regulated pharmaceutical, biotech and medical device industries. The Company’s products consist of medical labels and supplementary printed materials included in prescription drug and medical device packaging.
For further information regarding Saugatuck and its investments, please visit www.saugatuckcapital.com.